Skip to main content

Want a detailed portfolio tracker?

YD Bio (YDES) P/E (2025 - 2026)

YD Bio (YDES) P/E from Aug 18, 2025 to Jul 21, 2026. The TTM YD Bio (YDES) P/E is -19.34. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of YD Bio (YDES)

YearP/EChange
2026-19.34-81.38%
2025-103.84N/A

Comparison YD Bio (YDES) P/E with competitors

YD Bio (YDES) P/E is -19.34.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.01%
NBYStablecoin Development Corp0.00-100.02%
ENLVEnlivex Ltd0.07-100.39%
FGENFibroGen Inc0.24-101.24%
CHRSCoherus Biosciences Inc0.85-104.39%
FBIOFortress Biotech Inc0.95-104.91%
ORMPOramed Pharmaceuticals Inc1.50-107.77%
AGENAgenus Inc3.01-115.56%
INVAInnoviva Inc3.15-116.31%
VXRTVaxart Inc3.55-118.36%
CRMDCorMedix Inc3.63-118.76%
CVACCureVac N.V.4.45-122.99%
GLPGGalapagos NV4.86-125.13%
SRPTSarepta Therapeutics Inc4.88-125.25%
ABEOAbeona Therapeutics Inc5.39-127.86%
ABUSArbutus Biopharma Corp5.60-128.94%
ZVRAZevra Therapeutics Inc5.89-130.44%
SPROSpero Therapeutics Inc6.23-132.21%
CGENCompugen Ltd6.31-132.65%
RIGLRigel Pharmaceuticals6.87-135.54%
SLXNSilexion Therapeutics Corp7.30-137.73%
OMEROmeros Corporation9.26-147.88%
AUPHAurinia Pharmaceuticals Inc9.58-149.57%
PLXProtalix BioTherapeutics Inc10.89-156.32%
ACADAcadia Pharmaceuticals Inc11.73-160.65%
TBPHTheravance Biopharma Inc12.26-163.41%
ADMAAdma Biologics Inc12.42-164.22%
HRMYHarmony Biosciences Holdings Inc13.82-171.47%
SABSSAB Biotherapeutics Inc14.14-173.10%
NAGENiagen Bioscience Inc14.82-176.63%
INCYIncyte Corp15.82-181.82%
REGNRegeneron Pharmaceuticals Inc15.86-182.00%
PBYIPuma Biotechnology Inc17.32-189.54%
CPRXCatalyst Pharmaceuticals Inc17.44-190.18%
EXELExelixis Inc17.54-190.69%
TGTXTG Therapeutics Inc18.97-198.08%
MDXGMimedx Group Inc20.55-206.28%
XOMAXOMA Royalty Corp22.87-218.29%
ARGXArgen X SE24.30-225.65%
CTMXCytomX Therapeutics Inc24.82-228.36%
XOMAOXOMA Royalty Corp25.34-231.07%
HALOHalozyme Therapeutics Inc25.62-232.51%
XOMAPXOMA Royalty Corp25.67-232.75%
VRTXVertex Pharmaceuticals Inc27.99-244.77%
RPRXRoyalty Pharma plc - Class A28.69-248.35%
SLNOSoleno Therapeutics Inc29.02-250.05%
ASNDAscendis Pharma A/S30.09-255.58%
LGNDLigand Pharmaceuticals Inc - Class B37.91-296.06%
APLSApellis Pharmaceuticals Inc39.02-301.79%
BMRNBiomarin Pharmaceutical Inc42.21-318.29%
KRYSKrystal Biotech Inc45.34-334.49%
ONCBeiGene Ltd69.54-459.62%
PHARPharming Group N.V.75.03-487.98%
TECHBio-Techne Corp101.96-627.26%
VCELVericel Corp109.92-668.44%
ALNYAlnylam Pharmaceuticals Inc117.96-710.04%
GMABGenmab140.29-825.49%
TLXTelix Pharmaceuticals Ltd162.15-938.55%
CORTCorcept Therapeutics Inc212.86-1200.76%